Results 31 to 40 of about 2,238,052 (265)

Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study

open access: yesBMC Surgery
Background Giant hepatic hemangiomas can cause significant symptoms or complications, and laparoscopic resection remains technically demanding. This study assessed the safety and feasibility of laparoscopic resection for giant hemangiomas.
Aleksander Tarasik   +10 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Radiation Therapy for Desmoid Tumors

open access: yes, 2011
Radiation therapy uses high-energy ionizing radiation beams to treat malignant cancers as well as a variety of benign tumors and medical conditions. James Ewing was the first to report the successful use of radiotherapy in the management of unresectable ...
Chen, Yen-Lin   +11 more
core   +1 more source

Tumor-derived apolipoprotein E confers resistance to temozolomide in pancreatic neuroendocrine tumors

open access: yesCell Death and Disease
Temozolomide (TMZ) is a first-class clinical drug for patients with pancreatic neuroendocrine tumors (pNETs). However, the therapeutic effects of TMZ are limited because of the chemoresistance of pNET cells, which has not been fully elucidated.
Xin Lou   +15 more
doaj   +1 more source

Diagnostic traps in orbital diseases – analysis and comparison of two cases

open access: yesAnnales Academiae Medicae Silesiensis, 2022
Proptosis is a characteristic sign that might suggest the diagnosis of different diseases. Proptosis is characterised by the anterior displacement of the eye and its protrusion.
Mateusz Kamil Świątek   +4 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Malignant pediatric tumors in : Orbital Tumors

open access: yes, 2005
Part V Pediatric Orbital Tumors and Pseudotumors 26 .
HADJISTILIANOU, THEODORA, KARCIOGLU Z.
core   +1 more source

Inhibition of SIRT7 Overcomes Radioresistance in Pancreatic Neuroendocrine Tumors by Reactivating MEN1 Expression

open access: yesAdvanced Science
Pancreatic neuroendocrine tumors (PanNETs) frequently exhibit loss or reduced expression of the tumor suppressor MEN1, a key regulator of tumor progression and DNA damage response (DDR).
Jianyun Jiang   +11 more
doaj   +1 more source

Predictors of retreatment after radiofrequency ablation of benign thyroid nodules: role of pre-treatment growth rate and viable volume

open access: yesEuropean Thyroid Journal
Background: Radiofrequency ablation (RFA) has emerged as a minimally invasive and effective alternative to surgery for benign thyroid nodules, providing a significant volume reduction and symptom relief.
Adrien Ben Hamou   +5 more
doaj   +1 more source

Case of adenohypophysis adenocarcinoma according to postmortem results

open access: yesPatologìâ, 2012
This article describes a case of rare disease – adenocarcinoma of adenohypophysis. A tumour had extremely small size and was accompanied by destruction of wall of the sella turcica and invasion of blood vessels, that resulted in development of thrombosis
N. Yu. Ozerova
doaj   +1 more source

Home - About - Disclaimer - Privacy